CD8A and non-small cell lung carcinoma: Recent studies showed that transfecting cells with miRNAs not only inhibited the proliferation of NSCLC cells and reversed cisplatin resistance but also activated CD8+ T cells in a STAT3/PD-L1-dependent manner by binding to STAT3 3′-UTR [21,63].